Overview

Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
An 8-week, Open-Label Study to Characterize the Response to Modafinil (85mg Film-Coated Tablet) Treatment at Dosages up to 425mg/Day in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) (With an Open-Ended Extension Period)
Phase:
Phase 3
Details
Lead Sponsor:
Cephalon
Treatments:
Armodafinil
Modafinil